GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 96 filers reported holding GENMARK DIAGNOSTICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $608,000 | +181.5% | 25,424 | +72.0% | 0.00% | – |
| Q4 2020 | $216,000 | -98.1% | 14,785 | -98.1% | 0.00% | -100.0% |
| Q3 2020 | $11,281,000 | +5997.8% | 794,441 | +2944.5% | 0.00% | – |
| Q1 2019 | $185,000 | +54.2% | 26,094 | +6.0% | 0.00% | – |
| Q4 2018 | $120,000 | -45.0% | 24,621 | -16.8% | 0.00% | – |
| Q3 2018 | $218,000 | +52.4% | 29,610 | +32.4% | 0.00% | – |
| Q2 2018 | $143,000 | -80.2% | 22,368 | -63.3% | 0.00% | – |
| Q2 2017 | $721,000 | -15.6% | 60,919 | -12.7% | 0.00% | – |
| Q4 2016 | $854,000 | +1372.4% | 69,747 | +996.0% | 0.00% | – |
| Q2 2015 | $58,000 | -61.1% | 6,364 | -48.3% | 0.00% | – |
| Q3 2013 | $149,000 | +75.3% | 12,305 | +49.4% | 0.00% | – |
| Q2 2013 | $85,000 | – | 8,234 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 3,500,000 | $25,725,000 | 3.13% |
| CADIAN CAPITAL MANAGEMENT, LP | 3,830,399 | $28,153,000 | 1.28% |
| Mesirow Financial Investment Management, Inc. | 33,001 | $243,000 | 1.25% |
| Bellevue Group AG | 1,339,502 | $9,845,000 | 0.62% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 260,000 | $1,912,000 | 0.58% |
| Lyon Street Capital, LLC | 109,850 | $807,000 | 0.50% |
| Private Wealth Partners, LLC | 300,000 | $2,205,000 | 0.34% |
| Penn Capital Management Company, LLC | 455,064 | $3,345,000 | 0.25% |
| HighTower Advisors, LLC | 2,337,132 | $17,179,000 | 0.12% |
| Schonfeld Strategic Advisors LLC | 376,000 | $2,763,000 | 0.12% |